Blueprint for cancer research: Critical gaps and opportunities.
CA Cancer J Clin
; 71(2): 107-139, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33326126
ABSTRACT
We are experiencing a revolution in cancer. Advances in screening, targeted and immune therapies, big data, computational methodologies, and significant new knowledge of cancer biology are transforming the ways in which we prevent, detect, diagnose, treat, and survive cancer. These advances are enabling durable progress in the goal to achieve personalized cancer care. Despite these gains, more work is needed to develop better tools and strategies to limit cancer as a major health concern. One persistent gap is the inconsistent coordination among researchers and caregivers to implement evidence-based programs that rely on a fuller understanding of the molecular, cellular, and systems biology mechanisms underpinning different types of cancer. Here, the authors integrate conversations with over 90 leading cancer experts to highlight current challenges, encourage a robust and diverse national research portfolio, and capture timely opportunities to advance evidence-based approaches for all patients with cancer and for all communities.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Mass Screening
/
Evidence-Based Medicine
/
Professional Practice Gaps
/
Medical Oncology
/
Neoplasms
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
CA Cancer J Clin
Year:
2021
Type:
Article
Affiliation country:
Georgia